Commentary by Melissa Freeman MD, PGY2
Modern day science has revealed to us the intricate relationships that thyroid hormones have with multiple systems of the human body. Many of today’s physicians find themselves checking patients’ …
Commentary by Melissa Freeman MD, PGY2
Modern day science has revealed to us the intricate relationships that thyroid hormones have with multiple systems of the human body. Many of today’s physicians find themselves checking patients’ …
Commentary by Andrew Hardie MD, Body MRI Fellow, NYU Dept of Radiology
The recent discovery of a link between Nephrogenic Systemic Fibrosis (NSF) and the administration of gadolinium contrast for MRI examinations has sent the imaging world scrambling. …
Commentary by Cathy Cruise, M.D. Director Department of Veterans Affairs Care Coordinator, Chair Rehabilitation Council
Case: A 25 year old woman with no significant past medical history presents to walk-in clinic complaining of several days of right heel pain. …
Welcome to Class Act, a new feature of Clinical Correlations. Class act will feature posts written by NYU 3rd and 4th year medical students. These posts will focus on evidenced based answers to clinical questions related …

Commentary by Josh Olstein MD, Chief Resident NYU Internal Medicine
Mr. J is a 56 year old Caucasian gentleman who presented with complaints of “I just can’t do what I used to be able to do. I just …
Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program
A 66 year old woman with a history of dyslipidemia and remote tobacco use presents with a sudden onset of pain located in her posterior left thigh radiating down her …
Commentary by Sean Cavanaugh MD, Associate Editor, Clinical Correlations
A 51-year-old man with a history of DVT diagnosed seven months ago presents to your clinic for follow up. He has no family history of blood clots. He …

Commentary by Mitchell Charap MD, Senior Associate Program Director, NYU Internal Medicine Residency Program
Caveat: What follows below reflects my perspective on new and old pharmacologic approaches to Type 2 Diabetes. It is not intended to be …